Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families

Julie Jemutai; Louise Downs; Motswedi Anderson; Chari Cohen; Janet Seeley; Binta Sultan; Joy Ko; Stuart Flanagan; Collins Iwuji; Rachel Halford; Oriel Fernandes; Peter Vickerman; Asgeir Johannessen; Philippa C. Matthews

doi:10.1016/S2468-1253(24)00384-4

Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families

Julie Jemutai
, Louise Downs
, Motswedi Anderson
, Chari Cohen
, Janet Seeley
, Binta Sultan
, Joy Ko
, Stuart Flanagan
, Collins Iwuji
, Rachel Halford
, Oriel Fernandes
, Peter Vickerman
, Asgeir Johannessen
, Philippa C. Matthews

AkiliNook Research and Consulting
University of Oxford
KEMRI-Wellcome Trust Research Programme
Africa Health Research Institute
Mill Hill Laboratory
Botswana Harvard Health Partnership
Hepatitis B Foundation
London School of Hygiene and Tropical Medicine
University College London
Central and North West London NHS Foundation Trust
University College London Hospitals NHS Foundation Trust
University of Sussex
World Hepatitis Alliance
Clinton Healthcare Access Initiative
University of Bristol
University of Oslo

Research output: Contribution to journal › Comment/debate

8 Citations (Scopus)

Original language	English
Pages (from-to)	100-103
Number of pages	4
Journal	The Lancet Gastroenterology and Hepatology
Volume	10
Issue number	2
DOIs	https://doi.org/10.1016/S2468-1253(24)00384-4
Publication status	Published - 13 Nov 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2468-1253(24)00384-4

Cite this

Jemutai, J., Downs, L., Anderson, M., Cohen, C., Seeley, J., Sultan, B., Ko, J., Flanagan, S., Iwuji, C., Halford, R., Fernandes, O., Vickerman, P., Johannessen, A., & Matthews, P. C. (2024). Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families. The Lancet Gastroenterology and Hepatology, 10(2), 100-103. https://doi.org/10.1016/S2468-1253(24)00384-4

@article{9b56c000d394458093a04ad1b1d5a4e7,

title = "Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families",

author = "Julie Jemutai and Louise Downs and Motswedi Anderson and Chari Cohen and Janet Seeley and Binta Sultan and Joy Ko and Stuart Flanagan and Collins Iwuji and Rachel Halford and Oriel Fernandes and Peter Vickerman and Asgeir Johannessen and Matthews, \{Philippa C.\}",

year = "2024",

month = nov,

day = "13",

doi = "10.1016/S2468-1253(24)00384-4",

language = "English",

volume = "10",

pages = "100--103",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd",

number = "2",

}

Jemutai, J, Downs, L, Anderson, M, Cohen, C, Seeley, J, Sultan, B, Ko, J, Flanagan, S, Iwuji, C, Halford, R, Fernandes, O, Vickerman, P, Johannessen, A & Matthews, PC 2024, 'Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families', The Lancet Gastroenterology and Hepatology, vol. 10, no. 2, pp. 100-103. https://doi.org/10.1016/S2468-1253(24)00384-4

TY - JOUR

T1 - Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families

AU - Jemutai, Julie

AU - Downs, Louise

AU - Anderson, Motswedi

AU - Cohen, Chari

AU - Seeley, Janet

AU - Sultan, Binta

AU - Ko, Joy

AU - Flanagan, Stuart

AU - Iwuji, Collins

AU - Halford, Rachel

AU - Fernandes, Oriel

AU - Vickerman, Peter

AU - Johannessen, Asgeir

AU - Matthews, Philippa C.

PY - 2024/11/13

Y1 - 2024/11/13

U2 - 10.1016/S2468-1253(24)00384-4

DO - 10.1016/S2468-1253(24)00384-4

M3 - Comment/debate

C2 - 39681128

AN - SCOPUS:85214343326

SN - 2468-1253

VL - 10

SP - 100

EP - 103

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 2

ER -